Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREPaed: Treprostinil in Paediatric PAH
NCT06350032Phase 3Recruiting
- Sponsor
- AOP Health
- Start
- Jul 2024
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by AOP Health. Started Jul 2024; status: recruiting.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT06350032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350032.